ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction

Autoimmune Disease, Multisystem, with Facial Dysmorphism (ADMFD) is an autosomal recessive disorder due to pathogenic variants in the ITCH gene. It is characterized by failure to thrive, dysmorphic facial features, developmental delay, and systemic autoimmunity that can manifest variably with autoim...

Full description

Bibliographic Details
Main Authors: Rachel Wolfe, Paige Heiman, Olivia D'Annibale, Anuradha Karunanidhi, Alyssa Powers, Marianne Mcguire, Bianca Seminotti, Steven F. Dobrowolski, Miguel Reyes-Múgica, Kathryn S. Torok, Al-Walid Mohsen, Jerry Vockley, Lina Ghaloul-Gonzalez
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426922000921
_version_ 1811300269382696960
author Rachel Wolfe
Paige Heiman
Olivia D'Annibale
Anuradha Karunanidhi
Alyssa Powers
Marianne Mcguire
Bianca Seminotti
Steven F. Dobrowolski
Miguel Reyes-Múgica
Kathryn S. Torok
Al-Walid Mohsen
Jerry Vockley
Lina Ghaloul-Gonzalez
author_facet Rachel Wolfe
Paige Heiman
Olivia D'Annibale
Anuradha Karunanidhi
Alyssa Powers
Marianne Mcguire
Bianca Seminotti
Steven F. Dobrowolski
Miguel Reyes-Múgica
Kathryn S. Torok
Al-Walid Mohsen
Jerry Vockley
Lina Ghaloul-Gonzalez
author_sort Rachel Wolfe
collection DOAJ
description Autoimmune Disease, Multisystem, with Facial Dysmorphism (ADMFD) is an autosomal recessive disorder due to pathogenic variants in the ITCH gene. It is characterized by failure to thrive, dysmorphic facial features, developmental delay, and systemic autoimmunity that can manifest variably with autoimmune hepatitis, thyroiditis, and enteropathy, among other organ manifestations. It was originally described in 10 consanguineous Old Order Amish patients, and more recently in two patients of White British and Black German ethnicities. While the role of ITCH protein in apoptosis and inflammation has previously been characterized, a defect in cellular bioenergetics has not yet been reported in ITCH deficiency. Here we present a Caucasian female originally evaluated for possible mitochondrial respiratory chain deficiency, who ultimately was found to have two novel variants in ITCH with absence of ITCH protein in patient derived fibroblasts. Clinical studies of patient muscle showed mitochondrial DNA copy number of 57% compared to controls. Functional studies in skin fibroblasts revealed decreased activity of mitochondrial fatty acid oxidation and oxidative phosphorylation, and decreased overall ATP production. Our findings confirm mitochondrial energy dysfunction in a patient with ITCH deficiency offering the opportunity to assess alternative therapeutic options.
first_indexed 2024-04-13T06:48:33Z
format Article
id doaj.art-9763ee3b6cd345f3adadf389b4604dbf
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-04-13T06:48:33Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-9763ee3b6cd345f3adadf389b4604dbf2022-12-22T02:57:29ZengElsevierMolecular Genetics and Metabolism Reports2214-42692022-12-0133100932ITCH deficiency clinical phenotype expansion and mitochondrial dysfunctionRachel Wolfe0Paige Heiman1Olivia D'Annibale2Anuradha Karunanidhi3Alyssa Powers4Marianne Mcguire5Bianca Seminotti6Steven F. Dobrowolski7Miguel Reyes-Múgica8Kathryn S. Torok9Al-Walid Mohsen10Jerry Vockley11Lina Ghaloul-Gonzalez12Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USAUPMC Clinical Genomics Laboratory, UPMC Magee-Womens Hospital, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USADivision of Clinical Chemistry, Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USADivision of Clinical Chemistry, Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USADivision of Rheumatology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USADivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Corresponding author at: Division of Genetic and Genomic Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Rangos Research Building, Pittsburgh, PA 15224, USA.Autoimmune Disease, Multisystem, with Facial Dysmorphism (ADMFD) is an autosomal recessive disorder due to pathogenic variants in the ITCH gene. It is characterized by failure to thrive, dysmorphic facial features, developmental delay, and systemic autoimmunity that can manifest variably with autoimmune hepatitis, thyroiditis, and enteropathy, among other organ manifestations. It was originally described in 10 consanguineous Old Order Amish patients, and more recently in two patients of White British and Black German ethnicities. While the role of ITCH protein in apoptosis and inflammation has previously been characterized, a defect in cellular bioenergetics has not yet been reported in ITCH deficiency. Here we present a Caucasian female originally evaluated for possible mitochondrial respiratory chain deficiency, who ultimately was found to have two novel variants in ITCH with absence of ITCH protein in patient derived fibroblasts. Clinical studies of patient muscle showed mitochondrial DNA copy number of 57% compared to controls. Functional studies in skin fibroblasts revealed decreased activity of mitochondrial fatty acid oxidation and oxidative phosphorylation, and decreased overall ATP production. Our findings confirm mitochondrial energy dysfunction in a patient with ITCH deficiency offering the opportunity to assess alternative therapeutic options.http://www.sciencedirect.com/science/article/pii/S2214426922000921ITCHAutoimmune diseaseUbiquitinationApoptosisE3 ligaseMitochondrial dysfunction
spellingShingle Rachel Wolfe
Paige Heiman
Olivia D'Annibale
Anuradha Karunanidhi
Alyssa Powers
Marianne Mcguire
Bianca Seminotti
Steven F. Dobrowolski
Miguel Reyes-Múgica
Kathryn S. Torok
Al-Walid Mohsen
Jerry Vockley
Lina Ghaloul-Gonzalez
ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
Molecular Genetics and Metabolism Reports
ITCH
Autoimmune disease
Ubiquitination
Apoptosis
E3 ligase
Mitochondrial dysfunction
title ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
title_full ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
title_fullStr ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
title_full_unstemmed ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
title_short ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
title_sort itch deficiency clinical phenotype expansion and mitochondrial dysfunction
topic ITCH
Autoimmune disease
Ubiquitination
Apoptosis
E3 ligase
Mitochondrial dysfunction
url http://www.sciencedirect.com/science/article/pii/S2214426922000921
work_keys_str_mv AT rachelwolfe itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT paigeheiman itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT oliviadannibale itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT anuradhakarunanidhi itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT alyssapowers itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT mariannemcguire itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT biancaseminotti itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT stevenfdobrowolski itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT miguelreyesmugica itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT kathrynstorok itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT alwalidmohsen itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT jerryvockley itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction
AT linaghaloulgonzalez itchdeficiencyclinicalphenotypeexpansionandmitochondrialdysfunction